Prognostic Factors in Stage I Melanoma
Author Information
Author(s): JM Karjalainen, MJ Eskelinen, S Nordling, PK Lipponen, EM Alhava, V-M Kosma
Primary Institution: Kuopio University Hospital
Hypothesis
Can mitotic rate and S-phase fraction serve as reliable prognostic factors for stage I cutaneous malignant melanoma?
Conclusion
Mitotic activity index, volume-corrected mitotic index, and S-phase fraction are significant prognostic factors for stage I cutaneous malignant melanoma.
Supporting Evidence
- Mitotic activity index and S-phase fraction were significant predictors of recurrence-free survival.
- Bleeding and tumor thickness were also important prognostic factors.
- High S-phase fraction (>4%) predicted poor overall survival.
Takeaway
Doctors can use certain measurements of cancer cell growth to better predict how a melanoma will behave and how likely it is to come back.
Methodology
The study analyzed clinical data from 369 patients, focusing on mitotic indices and S-phase fraction in relation to survival outcomes.
Potential Biases
Potential biases due to the retrospective nature of the study and reliance on historical patient records.
Limitations
The study is retrospective and may have biases related to data collection and patient selection.
Participant Demographics
The cohort included 191 women (52%) and 178 men (48%) with a mean age of 55.5 years.
Statistical Information
P-Value
P = 0.0021 for tumor thickness, P = 0.0106 for bleeding, P = 0.0058 for MN index, P = 0.0002 for MAI, P = 0.004 for bleeding, P = 0.009 for SPF, P = 0.034 for male gender.
Confidence Interval
CI 2.1-39.7 for MAI and bleeding, CI 3.2-35.6 for MAI and SPF.
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website